Keywords: peers, praise, aventis, deal-making, fanco-german, drug, major

Peers praise Aventis' deal-making

Article | 15 September 2003

Fanco-German drug major Aventis Pharmaceuticals, fresh off its most-recent $150 million alliance with Regeneron to market a new cancer treatment (Marketletter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Aventis

Aventis Pharma

Amgen

Astra Zeneca

AstraZeneca

Go to company listing